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Lyophilized horse and fetal bovine sera are commonly incorporated into the growth media used for primary 
pituitary cell cultures. LHRH degrading activity has been assumed to exist in these preparations but has 
not actually been demonstrated. During our studies with pituitary cultures, it became necessary toascertain 
if LHRH inactivating activity could be demonstrated in these sera. Luteinizing hormone releasing hormone 
(LHRH) was p~n~ba~d in either serum-free medium or medium containing fetal bovine and horse serum. 
Whether LHRH was lost during these incubations was assessed by diminished immunoreactivity as indi- 
cated by radioimmunoassay (RIA) and by diminished biological activity as indicated by reduced release 
of LH from pituitary cell cultures. Both the RIA and bioassay results indicated LHRH inactivating activity; 
the loss of LHRH could be prevented by inch&on of bacitracin i  the incubations. 
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I. I~RODUCTION growth rn~i~ contain&g 1yophiIized horse and 
fetal bovine serum. 
We have reported a portion of our work study- 
ing luteinizing hormone releasing hormone 
(LHRH) effects in the release of gonadotropins 
from monolayer pituitary cell cultures [1,2] and 
from superfused pituitary cultures attached to 
Cytodex I beads [3-51. Prior to LHRH exposure in 
these and similar studies, the serum-containing 
growth m~um was replaced by a highly defined 
medium. Because the’ serum seems to serve a vital 
but undefined role in culture survival, we were led 
to ponder how cellular response to a given LHRH 
regimen would compare in the defined serum-free 
medium as opposed to a complete serum- 
containing medium such as that in which the cells 
were initially grown; however, whole serum from 
humans and rats has been reported to contain 
LHRH ina~ivating activity [6]; it has not been 
reported whether similar activity exists in the 
lyophilized commercially available horse and fetal 
bovine sera commonly incorporated into growth 
media. Here we investigate LHRH inactivation in 
2. MATERIALS AND METHODS 
2.1. S&dies in fetar bovine and horse serum to 
detect he presence of LNRH crossremting 
material 
Initial studies were conducted to determine if 
horse and fetal bovine sera contained material 
which depressed binding in the LHRH radioim- 
munoassay (RIA). Following reconstitution of the 
lyophilized products, each serum was assayed in- 
dividually prior to charcoal stripping; in addition, 
the sera combined in equal proportion (the propor- 
tions in which they were included in the growth 
medium) were assayed prior to as well as subse- 
quent to charcoal stripping. 
2.2. Preparation of complete growth medium 
The culture medium was composed of Dulbec- 
co’s Modified Eagle Medium (DMEM) (Gibco 
no.320-1965) supplemented with 15% charcoal- 
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stripped fetal calf serum (Difco no.5065~67) and 
15% horse serum (Difco no.5357-67). The sera 
were lyophiliied when purchased and subsequently 
r~o~tituted in distilled water (Gibco no.670- 
5230), Penic~lin-str~tomy~ (Gibco no.600- 
5140), fungizone (Gibco no&Xl-5295) and non- 
essential amino acids (Gibco no.320- 1140) were 
added at 1% concentration. 
2.3. ~ein~bation of LHRH with serum- 
containing rowth medium 
In order to assess the effect of horse and fetal 
bovine serum on the stability of LHRH, 50-ng 
quantities of LHRH were incubated at 37°C in 
either 1 ml 0.01 M phosphate-buffered saline + 
0.1% gelatin (PBS + gel) for 60 min or 1 ml com- 
plete growth medium for 15, 30 and 60 min. 
f&-mm incubations in complete growth medium 
containing 1 .O mM bacitracin were also conducted 
in order to ascertain that, if LHRH loss were 
observed, it was indeed due to peptidase nzyme 
activity. At the end of the incubations, the reac- 
tions were stopped by heating at 100°C for 3 min. 
After centrifugation to remove precipitated pro- 
tein, aliquots of the medium were assayed by RIA 
and bioassay techniques for indications of 
diminished LHRH. Each serum was not assayed 
individually for LHRH inactivating activity 
because they were not incor~rat~ into growth 
medium individually. 
2.4. Radioimmunoassay procedures for LH and 
LHRH 
Luteinizing hormone (LH) levels were estimated 
in a double antibody RIA utilizing NIAMDD 
reagents as previously described f2,9]. The intra- 
assay coefficient of variation did not exceed 10070, 
while the inter-assay coefficient of variation did 
not exceed 15% (n = 18). LHRH was iodinated ac- 
cording to the lactoperoxidase-Hz02 method 
[lo,1 11. LHRH levels were beats in a double 
antibody RIA as previously described 1121. The 
intra-assay coefficient of variation did not exceed 
10070, while the inter-assay variation did not exceed 
15%. 
2.5. Bioassay to detect LHRH inactivation 
Monolayer pituitary cell cultures [2] were used 
to conduct he bioassay for LHRH inactivation. 
These studies utilized intact, Holtzman (Madison, 
102 
WI) albino male rats at 60 days of age. They were 
maintained under day cycles of 14 h light and 10 h 
darkness (lights on at 06.00 and off at 20.00 h). 
The rats and the cell cultures were prepared as 
previously described [2,5]. At 3 days (72 h), the 
complete serum-containing growth medium was 
substituted by DMEM (either 0.9 or 0.95 ml) 
without serum; the source of LHRH, either con- 
trol preincubations (in PBS + gel or in heat- 
inactivated growth medium) or experimental prein- 
cubations (unheated growth medium) was then 
added, either in 100 pl or in 50 ,& to make a total 
volume of 1 ml. Following a 3-h incubation, the 
media were removed and LH release was estimated 
by RIA. Duncan’s New Multirange test [13] was 
used to judge the si~~c~~ of decreased LHRH 
levels or decreased LHRH biological activity. 
3. RESULTS AND DISCUSSION 
Immunoreactive LHRH cross-reacting material 
was observed in serum (fig.l); prior to charcoal 
stripping (bar l), such material was observed in 
horse serum while in bovine serum (bar 2) essen- 
.2 
8 
Fig. 1. Immunoreactive LHFU-I cross-reacting material 
observed before charcoal stripping in (1) horse serum, 
(2) fetal bovine serum and (3) the two sera mixed in 
equal proportions, as well as (4) after charcoal stripping 
in the two sera mixed unheated, and (5) sub~uent to 
100°C for 3 min. In this and subsequent figures, values 
are plotted as the mean (zt SE) of triplicate 
determinations. 
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tially no such material was found. Bars 3 and 4 in- 
dicated cross-reacting material in a mixture of 
equal parts of the two sera before and after char- 
coal stripping, respectively, and that mixing equal 
parts of the two sera diluted the substance in half. 
Immunoreactivity of the substance was eliminated 
by 3 min at 100°C (bar 5). 
When LHRH at a concentration of 5 ng/lOO ~1 
was incubated in the presence of PBS + gel or heat- 
inactivated (KKK for 3 min) growth medium 
(fig.2; bars 1,2), RIA indicated no significant 
LHRH loss. When incubation was for increasing 
periods of time in the presence of complete growth 
medium (bars 3-9, progressive LHRH loss was 
observed; all 3 time points were significantly (P < 
0.01) lower than starting levels. If 1.0 mM 
bacitracin were included in the incubations (bar 6), 
the significant loss of LHRH was not detectable. 
Monolayer cultures were used to determine 
biological activity in response to LHRH prein- 
cubated at a concentration of 5 ng/lQO~l in the 
presence of buffer or complete growth medium 
(fig.3). The response to control (no LHRH) in- 
cubations (bars 1,2) indicated that growth medium 
containing stripped sera had no more effect on 
1 
Fig.2. Effects on the RIA detectable levels of LHRH 
(original concentration = 5 ng/lOOpl) subsequent to 
incubation in (1) PBS + gel, (2) heat-killed (lOO°C for 
3 min) complete growth medium, as well as (3-S) effects 
following incubation for increasing periods of time in 
the presence of unheated complete growth medium in 
the absence and (6) in the presence, of 1.0 mM 
bacitracin. The length of incubation prior to heat 
inactivation (lOO°C for 3 min) is indicated within each 
bar. All incubations were at 37V. 
INCUBATION + 
Fig.3. LH released from monolayer pituitary cell 
cultures derived from &day intact male rats in response 
to (1) DMEM only, (2) growth medium only, (3) 100 ,~l 
of an LHRH solution subsequent to 60 min 
preincubation in 0.01 M PBS + 0.1% gelatin (5 ng 
LHRH/lOOpl), (4-6) 50~1 of an LHRH solution 
(5 ng/lOO ,ul) diluted in growth medium and assayed for 
biological activity subsequent to 15, 30 and 60 min 
preincubation, respectively, in the absence and (7) in the 
presence, of 1 .O mM bacitracin. All preincubations were 
performed at 37°C. 
basal LH release than did DMEM alone; the 
LHRH cross-reacting material (fig. 1) therefore ap- 
parently had no biological activity as far as LH 
release was concerned. Bacitracin at 1.0 mM con- 
centration in either DMEM or growth medium had 
no further effect on basal release (not shown). Bar 
3 indicates the response to the LHRH buffer con- 
trol dilution (5 ng LHRH). The LH release in- 
duced by 50~1 of LHRH solution (which would 
correspond to 2.5 ng LHRH in the absence of in- 
activating activity) preincubated in growth medium 
for 15, 30 and 60 min is shown in bars 4-6; the 
bioassay system reflected the previously discussed 
RIA indicated loss of LHRH. Inclusion of 1 .O mM 
bacitracin would prevent this loss of biological ac- 
tivity (bar 10). 
In summary, horse serum was observed to con- 
tain material (2 ng/ml) which depressed binding in 
the LHRH RIA; this material was not detectable in 
fetal bovine serum. The material was heat labile, 
was not removed during charcoal stripping and 
had no LH-releasing biological activity. The 
presence of cross-reacting material has been 
reported by several investigators in different 
tissues [14-171. Here, its identity was not in- 
vestigated further; however, in view of the fact 
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that subsequent studies showed a loss of LHRH, it 
is conceivable that the cross-reacting material 
might actually be due to enzymatic tracer damage 
during the RIA incubation process. Subsequent to 
15, 30- and 60-min incubations at 37”C, initial 
concentrations of 5 ng LHRH/lOOpl in growth 
medium indicated progressive losses of im- 
munoreactive LHRH; comparable losses of 
biological activity were also noted as indicated by 
LH release. That the LHRH loss was due to pep- 
tidase activity was indicated by the fact that the in- 
clusion of bacitracin (1.0 mM) in the incubations 
prevented significant loss of LHRH im- 
munological or biological activity. The observed 
inactivation is especially of interest since it has 
been recommended in the literature [18] that fetal 
bovine serum be added to the incubation media 
from pituitary cell cultures in order to stabilize 
released LH. If one were interested in determining 
LHRH levels remaining subsequent o gonadotro- 
pin release, inaccurate values might be obtained. 
Some studies [19] indicate that fetal bovine serum 
exhibits no effect on LHRH-induced LH release 
from pituitary cultures; in view of the fact that the 
serum was removed prior to LHRH administra- 
tion, caution should be exercised in attempting to 
apply these conclusions to a system in which serum 
and LHRH were utilized simultaneously. 
To our knowledge, this is the first detailed 
report actually confirming LHRH inactivating ac- 
tivity in the lyophilized horse and fetal bovine sera 
which are widely incorporated into pituitary cell 
culture media; these studies have also indicated 
that this inactivating activity, as previously 
reported in other mammalian systems [ 18,201, is 
inhibitable by bacitracin. This may suggest 
methodological modifications in certain pituitary 
culture procedures. 
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